Brussels, 06/06/2000 (Agence Europe) - Since the start of the year, the European Commission launched several workshops in view of reviewing industrial policy in the medicine sector.
The most important work concerns the review of the approval system for marketing, which presently involves a centralised procedure, through the European Agency for the Evaluation of Medicinal Products (EMEA) in London, and a mechanism for mutual recognition. The centralised procedure is generally appreciated for...